MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Taysha Gene Therapies (TSHA) Earnings Date & Reports
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS... Show more
A.I. Advisor
published Earnings
TSHA is expected to report earnings to rise 7.69% to -14 cents per share on November 03
Q3'26
Est.
$-0.14
Q2'26
Missed
by $0.01
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.02
Q3'25
Est.
$-0.09
The last earnings report on August 11 showed earnings per share of -12 cents, missing the estimate of -11 cents. With 1.96M shares outstanding, the current market capitalization sits at 1.34B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
99
Web
https://www.tayshagtx.com